Journal Information Content Entity Continuant Continuant Entity Entity Periodical Generically Dependent Continuant Collection 2025-05-08T05:51:24 RDF description of Diabetes Technology & Therapeutics - http://repository.healthpartners.com/individual/journal-Diabetes-Technology---Therapeutics Advanced meter features improve postprandial and paired self-monitoring of blood glucose in individuals with diabetes: results of the Actions with the CONTOUR Blood Glucose Meter and Behaviors in Frequent Testers (ACT) study Time in range, time in tight range, and average glucose relationships are modulated by glycemic variability: identification of a glucose distribution model connecting glycemic parameters using real-world data A scalable application of artificial intelligence-driven insulin titration program to transform type 2 diabetes management First outpatient evaluation of a tubeless automated insulin delivery system with customizable glucose targets in children and adults with type 1 diabetes A randomized controlled trial using continuous glucose monitoring to guide food choices and diabetes self-care in people with type 2 diabetes not taking insulin Lost in translation: a disconnect between the science and Medicare coverage criteria for continuous subcutaneous insulin infusion Does availability of AIR insulin increase insulin use and improve glycemic control in patients with type 2 diabetes? Continuous glucose monitoring-based titration of once-weekly insulin icodec in insulin-naive individuals with type 2 diabetes (onwards 9): a phase 3b, multicenter, single-arm, treat-to-target clinical trial What's wrong with this picture? A critical review of current Centers for Medicare & Medicaid Services coverage criteria for continuous glucose monitoring [review] Increased derived time in range is associated with reduced risk of major adverse cardiovascular events, severe hypoglycemia, and microvascular events in type 2 diabetes: a post hoc analysis of DEVOTE A comparison of postprandial glucose control in the Medtronic advanced hybrid closed-loop system versus 670G Primary care and diabetes technologies and treatments [review] Making sense of glucose monitoring technologies: from SMBG to CGM State of type 1 diabetes management and outcomes from the T1D Exchange in 2016-2018 Current status and future directions for electronic point-of-care clinical decision support to improve diabetes management in primary care Remote application and use of real-time continuous glucose monitoring by adults with type 2 diabetes in a virtual diabetes clinic Impact of continuous glucose monitoring versus blood glucose monitoring to support a carbohydrate-restricted nutrition intervention in people with type 2 diabetes Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP) Baseline predictors of A1C reduction in adults using sensor-augmented pump therapy or multiple daily injection therapy: the STAR 3 experience The association of biochemical hypoglycemia with the subsequent risk of a severe hypoglycemic event: analysis of the DCCT data set Benefit of continuous glucose monitoring in reducing hypoglycemia is sustained through 12 months of use among older adults with type 1 diabetes Lived experience of advanced hybrid closed-loop versus hybrid closed-loop: patient-reported outcomes and perspectives International Forum for the Advancement of Diabetes Research and Care, April 29-30, 2011, Athens, Greece Implementation of basal-bolus therapy in type 2 diabetes: a randomized controlled trial comparing bolus insulin delivery using an insulin patch with an insulin pen Assessment of the glucose management indicator using different sampling durations Primary care and diabetes technologies and treatments [review] Role of continuous glucose monitoring in clinical trials: recommendations on reporting [review] Hypoglycemia in older adults with type 1 diabetes Primary care and diabetes technologies and treatments [review] Safety and glycemic outcomes during the MiniMed(TM) advanced hybrid closed-loop system pivotal trial in children and adolescents with type 1 diabetes Real-world evidence supporting Tandem Control-IQ Hybrid Closed-Loop success in the Medicare and Medicaid type 1 and type 2 diabetes populations public Primary care and diabetes technologies and treatments [review] Diabetes Technology & Therapeutics Safety and glycemic outcomes during the MiniMed� Advanced Hybrid Closed-Loop System Pivotal Trial in adolescents and adults with type 1 diabetes Long-term improvements in glycemic control with dexcom CGM use in adults with noninsulin-treated type 2 diabetes Impact of temporary glycemic target use in the hybrid and advanced hybrid closed-loop systems Continuous glucose monitoring for type 2 diabetes: how does it compare with type 1 diabetes [editorial]? Ultra-rapid lispro improves postprandial glucose control and time in range in type 1 diabetes compared to lispro: PRONTO-T1D Continuous Glucose Monitoring Substudy Coverage for continuous glucose monitoring for individuals with type 2 diabetes treated with nonintensive therapies: an evidence-based approach to policymaking [review] Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes Continuous glucose monitoring-measured glucose levels during oral glucose tolerance testing in pregnancy Continuous glucose monitoring metrics and hemoglobin A1c relationship in patients with type 2 diabetes treated by hemodialysis Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM) [review] Safety and effectiveness of MiniMed� 780G advanced hybrid closed-loop insulin intensification in adults with insulin-requiring type 2 diabetes Evaluating the accuracy, reliability, and clinical applicability of continuous glucose monitoring (CGM): is CGM ready for real time? A comparison of continuous glucose monitoring estimated hemoglobin A1c in adults with type 1 or type 2 diabetes Expert panel recommendations for a standardized ambulatory glucose profile report for connected insulin pens Prevalence, cost, and burden of diabetic ketoacidosis [review] Rationale and design for a GRADE substudy of continuous glucose monitoring Utilizing the ambulatory glucose profile to standardize and implement continuous glucose monitoring in clinical practice [review] Impact of modem-transferred blood glucose data on clinician work efficiency and patient glycemic control Discordance between glucose management indicator and glycated hemoglobin in people without diabetes Two years with a tubeless automated insulin delivery system: a single-arm multicenter trial in children, adolescents, and adults with Type 1 diabetes Primary care and diabetes technologies and treatments [review] journal-Diabetes-Technology---Therapeutics Detection of hypoglycemia with continuous interstitial and traditional blood glucose monitoring using the FreeStyle Navigator Continuous Glucose Monitoring System Ultrarapid lispro demonstrates similar time in target range to lispro with a hybrid closed-loop system A comparison between simplified and intensive dose-titration algorithms using AIR inhaled insulin for insulin-naive patients with type 2 diabetes in a randomized noninferiority trial Improved glycemia with hybrid closed-loop versus continuous subcutaneous insulin infusion therapy: results from a randomized controlled trial Efficacy and safety of flexible versus fixed dosing intervals of insulin glargine 300 U/mL in people with type 2 diabetes Can a tool that automates insulin titration be a key to diabetes management? The optimal duration of a run-in period to initiate continuous glucose monitoring for a randomized trial Is it time to move beyond TIR to TITR? Real-world data from over 20,000 users of continuous glucose monitoring in patients with type 1 and type 2 diabetes [review] Health-related quality of life and treatment satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) trial Comparison of a novel insulin bolus-patch with pen/syringe injection to deliver mealtime insulin for efficacy, preference, and quality of life in adults with diabetes: a randomized, crossover, multicenter study Real-world, patient-reported and clinic data from individuals with type 1 diabetes using the MiniMed 670G hybrid closed-loop system Glycemic outcomes persist for up to 2 years in very young children with the Omnipod(®) 5 Automated Insulin Delivery System Optimal sampling duration for continuous glucose monitoring to determine long-term glycemic control Novel pattern identification through standardized data display using the ambulatory glucose profile (AGP) report [abstract] A comparison of continuous glucose monitoring-measured time-in-range 70-180 mg/dL versus time-in-tight-range 70-140 mg/dL Comparison of second-generation basal insulin analogs: a review of the evidence from continuous glucose monitoring [review] The digital/virtual diabetes clinic: the future Is now-recommendations from an international panel on diabetes digital technologies introduction Continuous glucose monitoring integration for remote diabetes management: virtual diabetes care with case studies Clinical use of continuous glucose monitoring in adults with type 2 diabetes [review] Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis A call-to-action to eliminate barriers to accessing automated insulin delivery systems for people with type 1 diabetes The relationship between percent time <70 mg/dL and percent time <54 mg/dL measured by continuous glucose monitoring Continuous glucose monitoring prediction of gestational diabetes mellitus and perinatal complications Personalized glycated hemoglobin in diabetes management: closing the gap with glucose management indicator [review] Self-Monitoring of Blood Glucose (SMBG) Applications and Beyond, 2nd Annual Symposium, May 7-10, 2009, Berlin, Germany Decreasing the burden of carbohydrate counting and meal announcement with automated insulin delivery, meal recognition, and autocorrection doses: a case study [review]